Delivery Order SPE2DB22D6029-SPE2DB24FLTJP
Award Date
9/27/24
Potential Completion Date
10/21/24
Potential Value
$25K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $77,433.35, is for the delivery of Revlimid 25 mg capsules. It is a firm-fixed-price delivery order contract with an ultimate completion date of August 29, 2022. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $27,599.94 firm fixed price delivery order is for the supply of Revlimid 5 mg capsules. The order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for the supply of REVLIMID 10 MG Capsules. The award has a ceiling value of $105,612.88 and an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside...
This federal contract award is a delivery order with a ceiling value of $24,963.40 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REVLIMID 5 MG CAPSULE 28S, a pharmaceutical product, with a period of performance through November 2024. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $178,310.12, is a Firm Fixed Price Delivery Order for the supply of REVLIMID 10 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of April 11, 2025 and was awarded on March 21, 2025. The contract is not designated with a set-aside requirement, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $89,155.06 firm fixed-price delivery order contract is for the supply of REVLIMID 15 MG CAPSULE 100S, a prescription medication. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor for this award, which is associated with a larger...
This federal contract award is for the delivery of Revlimid 5 mg capsules to various military and federal healthcare facilities. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $96,231.34, was awarded on November 10, 2021, with a completion date of December 3, 2021. The contract is a Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen Drug Corp is a...
This federal contract award is for the delivery of REVLIMID 25 MG CAPSULE 100S to the Defense Logistics Agency (DLA), a defense agency. The award, with a ceiling value of $105,793.54, was made to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, located in Conshohocken, Pennsylvania. The contract is a firm fixed price delivery order without any set-aside designation. In addition to this award, Amerisourcebergen Drug Corp...
This is a $37,445.14 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of REVLIMID 25 MG CAPSULE 21S, a pharmaceutical product. The contract has an ultimate completion date of October 1, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these medical supplies through a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $77,433.35 fixed-price contract is for the delivery of REVLIMID 25 MG CAPSULE 100S, a specialty pharmaceutical product. The contract has an ultimate completion date of July 27, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor and...